Cardinal Health Inc. Secures $1 Billion in Notes Offering to Fund Solaris Health Acquisition
Reuters
Aug 28
Cardinal Health Inc. Secures $1 Billion in Notes Offering to Fund Solaris Health Acquisition
Cardinal Health Inc. announced the completion of a public offering totaling $1 billion in aggregate principal through the issuance of two sets of notes. The company issued $600 million in 4.500% Notes due 2030 and $400 million in 5.150% Notes due 2035. This offering was executed under Cardinal Health's existing registration statement filed with the Securities and Exchange Commission. The notes will be governed by an indenture agreement with The Bank of New York Mellon Trust Company, N.A. as trustee. Cardinal Health plans to allocate the proceeds towards funding a portion of the acquisition of Solaris Health, along with covering related fees and expenses, while any unused funds will temporarily support general corporate purposes.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cardinal Health Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-25-189845), on August 27, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.